Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司
For research, development and manufacturing use only. Not for human or veterinary use.

Research Supplies & Solvents · Source-reviewed dossier

Lemon Bottle

Catalog Record — Composition Verification Pending

Lemon Bottle is presented as a proprietary multi-ingredient catalog solution. The current catalog record does not establish a complete quantitative composition, a single CAS identity or directly matching peer-reviewed evidence. FDA warns that unapproved fat-dissolving injections marketed online have been associated with infections, permanent scars, skin deformities, cysts and painful nodules.

Research use only Lot documents on request
Lemon Bottle research product family with 1 catalog variants
AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.

Product family

Compound overview

Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.

Product identity

Product type
Multi-component research blend
Catalog family
Lemon Bottle
Research category
Research Supplies & Solvents
Identity boundary
No single CAS, formula or molecular weight applies to an incompletely verified proprietary mixture.
Evidence status
Direct composition and peer-reviewed product evidence not verified
Intended use
Research, development and manufacturing use only

Literature reference parameters

Compound or material class
Proprietary multi-ingredient catalog solutionCatalog-family identity
Evidence scope
Direct composition and peer-reviewed product evidence not verifiedDo not generalize beyond the cited model
Source review
Primary or authoritative records linked belowChecked 2026-09-01

Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.

Mechanism of action

How Lemon Bottle is studied

A target-to-pathway view grounded in the linked research records.

No single verified molecular mechanism

A proprietary mixture cannot be assigned one receptor target or mechanism unless its complete composition and concentrations are documented.

Evidence and material boundary

Claims made for other fat-dissolving injections, individual ingredients or branded products cannot be transferred to this catalog solution.

Reported research findings

What published studies report about Lemon Bottle

Reported outcomes are paired with their experimental model and evidence boundary.

FDA safety communication

Unapproved fat-dissolving injections have caused serious reactions

FDA reports permanent scars, serious infections, deformities, cysts and deep painful nodules after unapproved fat-dissolving injections.

The communication addresses the product class and does not establish the composition of this catalog entry.

Read the primary study
Evidence gap

Catalog name is not a chemical identity

The available catalog record does not provide a verified quantitative formula that can be mapped to one molecular entity or one evidence base.

A current specification and lot COA are required before this page can leave the indexing hold.

Read the primary study
Translation boundary: findings are limited to the evidence level stated on each card. Experimental protocol quantities are research details, not usage instructions.

Catalog options

Variant specifications

Pack-level catalog data; lot-level controls remain document-specific.

Catalog no.LEMON
Pack size10 ml × 10 vials
Current variant
Specification & documents for LEMON

Product specification

Multi-component research blend · 10 ml/vial catalog presentation · 10-vial pack · component identity and ratio controlled by product specification.

Lot documentation

Request by lot: CoA, component identity and purity

Quality system

Quality documentation

Document availability is stated honestly and can vary by catalog variant or lot.

Lot-specific Certificate of AnalysisAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Product Specification SheetAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Analytical Method SummaryAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request

Analytical interpretation

Interpret the documents, not just the headline number.

Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.

Open the Quality & Documentation Hub

HPLC area ≠ assayA dominant peak does not establish target mass fraction.

Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.

Counterions affect contentWater, salt form and solvents change the as-is composition.

Storage needs a data basisShipping practice is not the same as stability evidence.

Evidence map

Research context

Published studies and regulatory records, not customer testimonials or usage guidance.

FDA safety communication

Unapproved fat-dissolving injections have caused serious reactions

The communication addresses the product class and does not establish the composition of this catalog entry.

View primary record
Evidence gap

Catalog name is not a chemical identity

A current specification and lot COA are required before this page can leave the indexing hold.

View primary record
Evidence boundary: each card states its evidence type. Human trials and regulatory records describe the studied or regulated intervention; preclinical records remain model-specific. None verifies the identity, quality, safety or efficacy of this catalog lot or provides usage instructions.

Literature basis

Curated references

Third-party publications selected for direct relevance.

  1. 01

    Using Fat-Dissolving Injections That Are Not FDA Approved Can Be Harmful

    U.S. Food and Drug Administration. Current consumer safety communication.

    FDA record
  2. 02

    Fraudulent Products

    U.S. Food and Drug Administration. Medication health-fraud resource.

    FDA record

Research FAQ

Lemon Bottle questions

Concise answers for researchers comparing identity, evidence and catalog variants.

What is Lemon Bottle?

Lemon Bottle is presented as a proprietary multi-ingredient catalog solution. The current catalog record does not establish a complete quantitative composition, a single CAS identity or directly matching peer-reviewed evidence. FDA warns that unapproved fat-dissolving injections marketed online have been associated with infections, permanent scars, skin deformities, cysts and painful nodules.

What evidence is available for Lemon Bottle?

No directly matching peer-reviewed intervention record or independently verified quantitative composition is currently published on this page.

Does the cited research validate this catalog material?

No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.

Which quality documents can be requested?

A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.

How should Lemon Bottle be stored?

Store at 2-8 °C. Do not freeze. Protect from light. Confirm the applicable storage statement on the product-specific specification and lot documentation.

Knowledge tools

Continue with structured evidence

Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.

Internal technical source review

Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.

Editorial status: NHD evidence editorial workflow · 2026-09-01 · Not independent medical review · Review policy

Technical procurement

Ready to request a quote?

Selected: LEMON · 10 ml × 10 vials